Endometriosis and the Risk of Ovarian Cancer: is MiR126 the Achille's Heel?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kralickova M, Lagana A, Ghezzi F, Vetvicka V
. Endometriosis and risk of ovarian cancer: what do we know?. Arch Gynecol Obstet. 2019; 301(1):1-10.
DOI: 10.1007/s00404-019-05358-8.
View
2.
Liu S, Gao S, Wang X, Wang D
. Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Arch Gynecol Obstet. 2011; 285(4):1065-72.
DOI: 10.1007/s00404-011-2112-6.
View
3.
Zhang Y, Qin X, Jiang J, Zhao W
. MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett. 2020; 20(2):1327-1335.
PMC: 7377137.
DOI: 10.3892/ol.2020.11687.
View
4.
Guo T, Yuan D, Lin M, Zhu D, Xu N, Wang J
. Aberrant expression of ADAM9 in ovarian cancer and its clinical significance. J Clin Lab Anal. 2019; 34(4):e23136.
PMC: 7171348.
DOI: 10.1002/jcla.23136.
View
5.
Hua Y, Liang C, Miao C, Wang S, Su S, Shao P
. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Oncol Lett. 2018; 15(6):9051-9060.
PMC: 5958673.
DOI: 10.3892/ol.2018.8528.
View